Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Fibroblast growth factor receptor 3 [397-806] | ||
Ligand | BDBM350059 | ||
Substrate/Competitor | n/a | ||
IC50 | 0.700±n/a nM | ||
Citation | Andrews, SW; Blake, JF; Cook, A; Gunawardana, IW; Hunt, KW; Metcalf, AT; Moreno, D; Ren, L; Tang, TP 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases US Patent US10766881 Publication Date 9/8/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Fibroblast growth factor receptor 3 [397-806] | |||
Name: | Fibroblast growth factor receptor 3 [397-806] | ||
Synonyms: | FGFR3 | FGFR3_HUMAN | Fibroblast growth factor receptor 3 (FGFR-3) | Fibroblast growth factor receptor 3 (FGFR3) (R397-T806) | JTK4 | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 45431.04 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P22607[397-806] | ||
Residue: | 410 | ||
Sequence: |
| ||
BDBM350059 | |||
n/a | |||
Name | BDBM350059 | ||
Synonyms: | US10208024, Example 58 | US10766881, Example 58 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H25Cl2N7O3 | ||
Mol. Mass. | 542.417 | ||
SMILES | COc1cc(OC)c(Cl)c(c1Cl)-n1nc(ccc1=O)-c1cc(cnc1N)-c1cnn(c1)C1CCNCC1 |(6.08,3.85,;7.42,3.08,;7.42,1.54,;8.75,.77,;8.75,-.77,;10.08,-1.54,;10.08,-3.08,;7.42,-1.54,;7.42,-3.08,;6.08,-.77,;6.08,.77,;4.75,1.54,;4.75,-1.54,;3.42,-.77,;2.08,-1.54,;2.08,-3.08,;3.42,-3.85,;4.75,-3.08,;6.08,-3.85,;.75,-.77,;-.58,-1.54,;-1.92,-.77,;-1.92,.77,;-.58,1.54,;.75,.77,;2.08,1.54,;-3.25,-1.54,;-3.25,-3.08,;-4.72,-3.56,;-5.62,-2.31,;-4.72,-1.06,;-7.11,-1.91,;-7.51,-.42,;-9,-.03,;-10.08,-1.11,;-9.69,-2.6,;-8.2,-3,)| | ||
Structure |